Toggle Main Menu Toggle Search


Pharmacological study of CT-2103 (XyotaxTM), a poly(L-glutamic acid)-paclitaxel conjugate administered every 3 weeks or every 2 weeks in a phase I study

Lookup NU author(s): Professor Alan Boddy, Dr Mark Verrill, Julieann Sludden, Kevin Fishwick, Lynsey Robson, Dr Jane Cassidy, Professor Alan Calvert


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Boddy, A. V., Todd, R., Verrill, M., Sludden, J., Fishwick, K., Robson, L., Cassidy, J., Bisset, D., Garzone, P. D., Calvert, A. H.

Publication type: Article

Journal: European Journal of Cancer

Year: 2002

Volume: 38

Issue: Supplement 7

Pages: S34 no. 98

ISSN (print): 0959-8049

ISSN (electronic): 1879-0852


DOI: 10.1016/S0959-8049(02)80747-X


Altmetrics provided by Altmetric


    Link to this publication